Lack of a time-factor in alternating chemoradiotherapy for advanced head and neck squamous cell carcinoma

Tumori

Volumn 87, Issue 1, 2001, Pages 10-13

  Sanguineti, G ^a   Benasso, M ^a   Corvo R ^a   Marcenaro, M ^a   Ricci, I ^a   D'Amico, M ^a   Mora, F ^a   Vitale, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemotherapy; Radiotherapy; Time factor

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL POPULATION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TIME;

EID: 0035056723     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700102     Document Type: Article

References (19)

1. Loss of local control with prolongation in radiotherapy
2. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003
3. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
4. Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment continually rapid proliferation unmasked
5. Applying radiobiological principles to combined modality treatment of head and neck cancer: The time factor
6. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses
7. Alternating chemoradiotherapy versus partly accelerated radiotherapy in advanced squamous cell carcinoma of the head and neck: Results of a phase III randomized trial
8. Evidence of cell kinetics as a predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer
9. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer
10. Influence of selection bias on dose-time analysis: A theoretical investigation
11. Pitfalls in estimating the influence of overall treatment time on local tumor control
12. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
13. Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: Predictive factors of outcome
14. Altered fractionation: Limited by mucosal reactions?
15. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
16. Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy
17. The influence of overall radiation time (ORT) in patients treated with chemoradiotherapy for squamous cancer of the head and neck
18. Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer
19. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers